TO COMPARE THE WEIGHT LOSS BETWEEN BANDED GASTRIC BYPASS PATIENTS AND NON BANDED GASTRIC BYPASS PATIENTS.BANDED GASTRIC BYPASS IS MEANT TO BE AN APPLICATION OF SILICONE BAND/RING AROUND THE STOMACH POUCH THAT IS CREATED INTRAOPERATIVELY FROM A PROPORTION OF PART OF STOMACH
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/05/042634
- Lead Sponsor
- Dept of surgical Disciplines AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Patients with morbid obesity, defined as Body Mass Index (BMI) > 37.5kg/m2.
2)Patients with BMI > 32.5 kg/m2 with obesity related co-morbidities.
3)Patients who have failed to maintain weight loss after trying appropriate non-surgical measures.
4)Patients who have comprehension and commitment to long term follow up.
5)Patients who gave consent for the study.
6)Age >18, & < 65
1)Any contraindication for bariatric surgery
There are no absolute contraindications for bariatric surgery.
Relative contraindications are:
-severe heart failure
-unstable coronary artery disease
-end-stage lung disease
-active cancer treatment
-portal hypertension
-drug/alcohol dependency
-impaired intellectual capacity
2)Patients requiring revision gastric bypass.
3)Refusal to participate in the study.
4)Ageless than18 & more than 65 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the mean percentage of excess weight loss (% EWL) at the end of 6 months & 1 year follow up period between patients who underwent banded Gastric bypass with non-banded gastric bypass procedures.Timepoint: At the end of 6 months & 1 year follow-up period.
- Secondary Outcome Measures
Name Time Method i.To compare the following for: <br/ ><br> 1.Mean OT time. <br/ ><br> 2.Mean length of hospital <br/ ><br> stay. <br/ ><br> 3.Incidence of <br/ ><br> complications, between <br/ ><br> the two procedures. <br/ ><br> 4.The impact of <br/ ><br> comorbidities (Diabetes <br/ ><br> Mellitus, Hypertension, <br/ ><br> Obstructive Sleep Apnea, <br/ ><br> Gastro-esophageal reflux <br/ ><br> disease, Dyslipidemia, <br/ ><br> Hypothyroidism) between <br/ ><br> the two types of <br/ ><br> procedures. <br/ ><br> 5.The quality of life <br/ ><br> (BAROS) score, GI quality <br/ ><br> of life score (GIQLI). <br/ ><br>Timepoint: At the end of 6 months & 1 year follow-up period.